Australian Therapeutic Goods Administration - Regulatory body for therapeutic goods in Australia
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Bifido Complex | Spectrumceuticals Pty Ltd | Medicine | Oct 28, 2024 | A |
| Amcal 50+ Men's Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
| Guardian Men's Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
| Hey Sister! LIFE Teen Period 28 tablets | Bioactive Laboratories Pty Ltd | Medicine | Oct 28, 2024 | A |
| Amcal Women's Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
| Hey Sister! LIFE Teen Period 84 tablets | Bioactive Laboratories Pty Ltd | Medicine | Oct 28, 2024 | A |
| Amcal 50+ Women's Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
| TELFAST ORAL LIQUID fexofenadine hydrochloride 6 mg/mL oral suspension bottle (clone) | Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare | Medicine | Oct 28, 2024 | A |
| A-one Herbal Topical Cream | Neo Health (OTC) Pty Ltd | Medicine | Oct 28, 2024 | A |
| Hi Life | Health Foundry Pty Ltd | Medicine | Oct 28, 2024 | A |
| Amcal Men's Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
| Blood Sugar Control with Berberine | Nature's Care Manufacture Pty Limited | Medicine | Oct 28, 2024 | A |
| Arthritis Calm | Botanature Pty Ltd | Medicine | Oct 28, 2024 | A |
| Guardian Women's 50+ Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
| Rest & Replenish Magnesium-Glycine Sleep Formula. | GOOD LIFE THORNLIE | Medicine | Oct 28, 2024 | A |
| Guardian Women's Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
| Guardian Men's 50+ Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
| Bifido Complex | Spectrumceuticals Pty Ltd | Medicine | Oct 28, 2024 | A |
| Amcal 50+ Men's Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
| Guardian Men's Multivitamins | Sigma Company Limited | Medicine | Oct 28, 2024 | A |
